Latest News and Press Releases
Want to stay updated on the latest news?
-
Las Vegas, Nevada, May 08, 2026 (GLOBE NEWSWIRE) -- High Roller Technologies, Inc. (“High Roller”) (NYSE: ROLR), a publicly traded online gaming and prediction markets company, today announced that...
-
NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Shreya Acquisition Group (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today...
-
NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Cornerstone Strategic Investment Fund, Inc. (NYSE American: CLM) (CUSIP: 21924B302) and Cornerstone Total Return Fund, Inc. (NYSE American: CRF) (CUSIP:...
-
NVIDIA Names Suzanne Nora Johnson to Board of Directors
-
~ Total Assets of $2.2 Billion and Over $2 Billion in Financial Assets* ~ ~ $17.9 Million Cash Provided by Operating Activities with Fourth Consecutive Quarter of Positive Operating Cash Flow ~ ~...
-
NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies...
-
NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD; HKEX: 0800), a global leader in autonomous driving technology, today announced that it will hold an...
-
Kfar Saba, Israel, May 08, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for...
-
CAMBRIDGE, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives...
-
First-in-primate data demonstrate in vivo generation of genomic site-specific engineered TRAC-CAR T cells following a single intravenous administration without lymphodepletionAll non-human primates (6...